Cibinqo Interactions
There are 552 drugs known to interact with Cibinqo (abrocitinib), along with 6 disease interactions, and 1 alcohol/food interaction. Of the total drug interactions, 255 are major, 251 are moderate, and 46 are minor.
- View all 552 medications that may interact with Cibinqo
- View Cibinqo alcohol/food interactions (1)
- View Cibinqo disease interactions (6)
Most frequently checked interactions
View interaction reports for Cibinqo (abrocitinib) and the medicines listed below.
- acetaminophen
- Adbry (tralokinumab)
- Adderall (amphetamine / dextroamphetamine)
- Adderall XR (amphetamine / dextroamphetamine)
- Aldactone (spironolactone)
- Alpha-Lipoic-Acid-300 (alpha-lipoic acid)
- Ambien (zolpidem)
- amiodarone
- amitriptyline
- amlodipine / benazepril
- Aquaphor (emollients topical)
- Arthrotec (diclofenac / misoprostol)
- Aspirin Low Strength (aspirin)
- Atrovent (ipratropium)
- azathioprine
- baclofen
- Benlysta (belimumab)
- betamethasone topical
- biotin
- brimonidine ophthalmic
- carvedilol
- clobetasol topical
- escitalopram
- Lyrica (pregabalin)
- methotrexate
- Mobic (meloxicam)
- Opzelura (ruxolitinib topical)
- rosuvastatin
- topiramate
- Vitamin D3 (cholecalciferol)
Cibinqo alcohol/food interactions
There is 1 alcohol/food interaction with Cibinqo (abrocitinib).
Cibinqo disease interactions
There are 6 disease interactions with Cibinqo (abrocitinib) which include:
- cardiovascular disease
- infections
- malignancies
- Abrocitinib -thrombosis
- liver dysfunction
- renal dysfunction
More about Cibinqo (abrocitinib)
- Cibinqo consumer information
- Compare alternatives
- Pricing & coupons
- Reviews (3)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: selective immunosuppressants
- Breastfeeding
- En español
Related treatment guides
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.